These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 7705075

  • 21. Measurements of glucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG-6-phosphate.
    Kuwabara H, Gjedde A.
    J Nucl Med; 1991 Apr; 32(4):692-8. PubMed ID: 2013809
    [Abstract] [Full Text] [Related]

  • 22. Generalized linear least squares algorithms for modeling glucose metabolism in the human brain with corrections for vascular effects.
    Cai W, Feng D, Fulton R, Siu WC.
    Comput Methods Programs Biomed; 2002 Apr; 68(1):1-14. PubMed ID: 11886698
    [Abstract] [Full Text] [Related]

  • 23. Evidence for dissociation of insulin stimulation of blood flow and glucose uptake in human skeletal muscle: studies using [15O]H2O, [18F]fluoro-2-deoxy-D-glucose, and positron emission tomography.
    Raitakari M, Nuutila P, Ruotsalainen U, Laine H, Teräs M, Iida H, Mäkimattila S, Utriainen T, Oikonen V, Sipilä H, Haaparanta M, Solin O, Wegelius U, Knuuti J, Yki-Järvinen H.
    Diabetes; 1996 Nov; 45(11):1471-7. PubMed ID: 8866549
    [Abstract] [Full Text] [Related]

  • 24. Cerebral metabolic rate for glucose during the first six months of life: an FDG positron emission tomography study.
    Kinnala A, Suhonen-Polvi H, Aärimaa T, Kero P, Korvenranta H, Ruotsalainen U, Bergman J, Haaparanta M, Solin O, Nuutila P, Wegelius U.
    Arch Dis Child Fetal Neonatal Ed; 1996 May; 74(3):F153-7. PubMed ID: 8777676
    [Abstract] [Full Text] [Related]

  • 25. The use of 2-[18F]fluoro-2-deoxy-D-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography.
    Osman S, Danpure HJ.
    Int J Rad Appl Instrum B; 1992 Feb; 19(2):183-90. PubMed ID: 1601671
    [Abstract] [Full Text] [Related]

  • 26. Error sensitivity of fluorodeoxyglucose method for measurement of cerebral metabolic rate of glucose.
    Huang SC, Phelps ME, Hoffman EJ, Kuhl DE.
    J Cereb Blood Flow Metab; 1981 Feb; 1(4):391-401. PubMed ID: 6976976
    [Abstract] [Full Text] [Related]

  • 27. A modeling method to improve quantitation of fluorodeoxyglucose uptake in heterogeneous tumor tissue.
    Wu HM, Huang SC, Choi Y, Hoh CK, Hawkins RA.
    J Nucl Med; 1995 Feb; 36(2):297-306. PubMed ID: 7830134
    [Abstract] [Full Text] [Related]

  • 28. Simultaneous emission and transmission (SET) scanning in neurological PET studies.
    Meikle SR, Eberl S, Hooper PK, Fulham MJ.
    J Comput Assist Tomogr; 1997 Feb; 21(3):487-97. PubMed ID: 9135664
    [Abstract] [Full Text] [Related]

  • 29. A general algorithm for optimal sampling schedule design in nuclear medicine imaging.
    Li X, Feng D, Wong K.
    Comput Methods Programs Biomed; 2001 Apr; 65(1):45-59. PubMed ID: 11223150
    [Abstract] [Full Text] [Related]

  • 30. Effect of vascular activity in the determination of rate constants for the uptake of 18F-labeled 2-fluoro-2-deoxy-D-glucose: error analysis and normal values in older subjects.
    Evans AC, Diksic M, Yamamoto YL, Kato A, Dagher A, Redies C, Hakim A.
    J Cereb Blood Flow Metab; 1986 Dec; 6(6):724-38. PubMed ID: 3491827
    [Abstract] [Full Text] [Related]

  • 31. Validation of postinjection transmission measurements for attenuation correction in neurological FDG-PET studies.
    Hooper PK, Meikle SR, Eberl S, Fulham MJ.
    J Nucl Med; 1996 Jan; 37(1):128-36. PubMed ID: 8543982
    [Abstract] [Full Text] [Related]

  • 32. A hybrid clustering method for ROI delineation in small-animal dynamic PET images: application to the automatic estimation of FDG input functions.
    Zheng X, Tian G, Huang SC, Feng D.
    IEEE Trans Inf Technol Biomed; 2011 Mar; 15(2):195-205. PubMed ID: 20952342
    [Abstract] [Full Text] [Related]

  • 33. Estimation of local cerebral glucose utilization by positron emission tomography: comparison of [18F]2-fluoro-2-deoxy-D-glucose and [18F]2-fluoro-2-deoxy-D-mannose in patients with focal brain lesions.
    Wienhard K, Pawlik G, Nebeling B, Rudolf J, Fink G, Hamacher K, Stöcklin G, Heiss WD.
    J Cereb Blood Flow Metab; 1991 May; 11(3):485-91. PubMed ID: 2016357
    [Abstract] [Full Text] [Related]

  • 34. Wilson's disease studied with FDG and positron emission tomography.
    Hawkins RA, Mazziotta JC, Phelps ME.
    Neurology; 1987 Nov; 37(11):1707-11. PubMed ID: 3499583
    [Abstract] [Full Text] [Related]

  • 35. Superimposition of PET images using 18F-fluorodeoxyglucose with magnetic resonance images in patients with pancreatic carcinoma.
    Benyounes H, Smith FW, Campbell C, Evans NT, Norton MY, Mikecz P, Heys SD, Bruce D, Eremin O, Sharp PF.
    Nucl Med Commun; 1995 Jul; 16(7):575-80. PubMed ID: 7478396
    [Abstract] [Full Text] [Related]

  • 36. Michaelis-Menten constraints improved cerebral glucose metabolism and regional lumped constant measurements with [18F]fluorodeoxyglucose.
    Kuwabara H, Evans AC, Gjedde A.
    J Cereb Blood Flow Metab; 1990 Mar; 10(2):180-9. PubMed ID: 2303534
    [Abstract] [Full Text] [Related]

  • 37. The use of spectral analysis to determine regional cerebral glucose utilization with positron emission tomography and [18F]fluorodeoxyglucose: theory, implementation, and optimization procedures.
    Turkheimer F, Moresco RM, Lucignani G, Sokoloff L, Fazio F, Schmidt K.
    J Cereb Blood Flow Metab; 1994 May; 14(3):406-22. PubMed ID: 8163583
    [Abstract] [Full Text] [Related]

  • 38. Correction of spillover radioactivities for estimation of the blood time-activity curve from the imaged LV chamber in cardiac dynamic FDG PET studies.
    Lin KP, Huang SC, Choi Y, Brunken RC, Schelbert HR, Phelps ME.
    Phys Med Biol; 1995 Apr; 40(4):629-42. PubMed ID: 7610118
    [Abstract] [Full Text] [Related]

  • 39. Investigations of cerebral glucose utilization into the newborn brain: a [18F]-FDG positron emission tomography study using a high resolution multiwire proportional chamber detector device.
    Bauer R, Bergmann R, Beyer GJ, Manfrass P, Steinbach J, Kretzschmar M, Enghardt W, Hoyer D, Günther K, Schubert H.
    Exp Pathol; 1991 Apr; 42(4):229-33. PubMed ID: 1959583
    [Abstract] [Full Text] [Related]

  • 40. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method.
    Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE.
    Ann Neurol; 1979 Nov; 6(5):371-88. PubMed ID: 117743
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.